Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Binnopharm Group creates logistics hub in China

12/18/25 AFKS

Yandex will launch delivery by robot couriers in all million-plus cities

12/18/25 YDEX

Kicksharing Yandex Go will reach 45 new cities with the help of a partner

12/18/25 YDEX

Turnover of the marketplace M.Video in November increased by 61.5%

12/18/25 MVID

Etalon sells the Silver Fountain business district

12/18/25 ETLN

Inter RAO increased its stake in Saratovenergo to 83%

12/18/25 IRAO

Inter RAO increased its stake in Saratovenergo to 83%

12/18/25 SARE

Moscow Exchange has launched a service for modeling investment portfolios

12/17/25 MOEX

Share of PIK-Investproekt LLC increased as a result of the closure of the forward

12/17/25 PIKK

PIK Group structure increased the share in the developer's capital to 21.9%

12/17/25 PIKK